{"id":"https://openalex.org/W7598045","doi":"https://doi.org/10.31083/ph.2013.2898","title":"Synthesis of telmisartan impurity B","display_name":"Synthesis of telmisartan impurity B","alternate_titles":[],"publication_year":2013,"publication_date":"2013-06-01","ids":{"openalex":"https://openalex.org/W7598045","doi":"https://doi.org/10.31083/ph.2013.2898","mag":"7598045","pmid":"https://pubmed.ncbi.nlm.nih.gov/23875243"},"language":"en","primary_location":{"id":"doi:10.31083/ph.2013.2898","doi":"https://doi.org/10.31083/ph.2013.2898","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2013.2898","pdf_url":"https://storage.imrpress.com/IMR/pharmazie/application/68_06_S392_395.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7598045"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://storage.imrpress.com/IMR/pharmazie/application/68_06_S392_395.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108320977","display_name":"Lun Zhao","orcid":"https://orcid.org/0009-0001-0103-8479","observed_orcids":["https://orcid.org/0009-0001-0103-8479"]},"institutions":[{"id":"https://openalex.org/I194450716","display_name":"Jilin University","ror":"https://ror.org/00js3aw79","country_code":"CN","type":"education","lineage":["https://openalex.org/I194450716"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lun Zhao","raw_affiliation_strings":["Pharmaceutical Company of Weihai Disu 3 , Weihai , PR China","College of Chemistry, Jilin University, Changchun, PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Company of Weihai Disu 3 , Weihai , PR China","institution_ids":[]},{"raw_affiliation_string":"College of Chemistry, Jilin University, Changchun, PR China","institution_ids":["https://openalex.org/I194450716"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Haijian Xia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haijian Xia","raw_affiliation_strings":["Pharmaceutical Company of Weihai Disu 3 , Weihai , PR China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Company of Weihai Disu 3 , Weihai , PR China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100784336","display_name":"Zichen Wang","orcid":"https://orcid.org/0000-0002-1415-1286","observed_orcids":["https://orcid.org/0000-0002-1415-1286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zi-Chen Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00025941,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"68","issue":"6","first_page":"392","last_page":"395"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":0.996999979019165},{"id":"https://openalex.org/keywords/synthetic-route","display_name":"synthetic route","score":0.5139999985694885},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8619999885559082},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.8880000114440918},{"id":"https://openalex.org/keywords/pharmaceutical-impurities","display_name":"drug impurities","score":0.699999988079071},{"id":"https://openalex.org/keywords/pharmaceutical-quality-control","display_name":"pharmaceutical quality control","score":0.8299999833106995},{"id":"https://openalex.org/keywords/structure-confirmation","display_name":"structure confirmation","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C2779716603","wikidata":"https://www.wikidata.org/wiki/Q733186","display_name":"Telmisartan","level":3,"score":0.9886419177055359},{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.8360000252723694},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.593579113483429},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5297119617462158},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.46969130635261536},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.4411681592464447},{"id":"https://openalex.org/C2777594072","wikidata":"https://www.wikidata.org/wiki/Q117247","display_name":"Pharmacopoeia","level":3,"score":0.4349799156188965},{"id":"https://openalex.org/C2780708007","wikidata":"https://www.wikidata.org/wiki/Q285044","display_name":"Angiotensin II receptor antagonist","level":5,"score":0.42135509848594666},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4200177788734436},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41641974449157715},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3535476326942444},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.34619608521461487},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.2976008653640747},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2612006366252899},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.228331059217453},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19395598769187927},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1607586145401001},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12502753734588623},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077333","descriptor_name":"Telmisartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D002850","descriptor_name":"Chromatography, Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002855","descriptor_name":"Chromatography, Thin Layer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004340","descriptor_name":"Drug Contamination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007202","descriptor_name":"Indicators and Reagents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011786","descriptor_name":"Quality Control","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012997","descriptor_name":"Solvents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021241","descriptor_name":"Spectrometry, Mass, Electrospray Ionization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.31083/ph.2013.2898","doi":"https://doi.org/10.31083/ph.2013.2898","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2013.2898","pdf_url":"https://storage.imrpress.com/IMR/pharmazie/application/68_06_S392_395.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},{"id":"pmid:23875243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23875243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"Journal Article"},{"id":"mag:7598045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23875243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"doi:10.31083/ph.2013.2898","doi":"https://doi.org/10.31083/ph.2013.2898","is_oa":true,"landing_page_url":"https://doi.org/10.31083/ph.2013.2898","pdf_url":"https://storage.imrpress.com/IMR/pharmazie/application/68_06_S392_395.pdf","source":{"id":"https://openalex.org/S175310056","display_name":"Die Pharmazie","issn_l":"0031-7144","issn":["0031-7144","3053-691X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320695","host_organization_name":"Avoxa","host_organization_lineage":["https://openalex.org/P4310320695"],"host_organization_lineage_names":["Avoxa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Die Pharmazie","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7598045.pdf","grobid_xml":"https://content.openalex.org/works/W7598045.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W1988080642","https://openalex.org/W2048983899","https://openalex.org/W2136394153","https://openalex.org/W4232582753"],"related_works":["https://openalex.org/W2045859283","https://openalex.org/W2048983899","https://openalex.org/W4413194508","https://openalex.org/W2374236971","https://openalex.org/W3164146678","https://openalex.org/W2603445395","https://openalex.org/W2317449229","https://openalex.org/W2898314223","https://openalex.org/W2528552160","https://openalex.org/W2953252586"],"abstract_inverted_index":{"Telmisartan":[0],"is":[1,6,33,41],"an":[2],"antihypertensive":[3],"drug":[4],"and":[5,37,66,81],"a":[7],"specific":[8],"angiotensin":[9],"II":[10],"receptor":[11],"(AT1)":[12],"antagonist.":[13],"According":[14],"to":[15],"European":[16],"Pharmacopoeia":[17],"7":[18],"Edition":[19],"2008":[20],"telmisartan":[21],"quality":[22,75,82],"standard,":[23],"there":[24],"are":[25],"seven":[26],"impurities":[27],"in":[28,78],"telmisartan.":[29,85],"Impurity":[30],"B":[31,58],"which":[32],"not":[34],"available":[35],"commercially":[36],"no":[38],"synthetic":[39],"method":[40],"published":[42],"so":[43],"far.":[44],"We":[45],"report":[46],"herein":[47],"the":[48,79],"first":[49],"synthesis":[50],"of":[51,56,84],"impurity":[52,57],"B.":[53],"The":[54],"structure":[55],"was":[59],"confirmed":[60],"by":[61],"1H":[62],"NMR,":[63],"13C":[64],"NMR":[65],"MS":[67],"data.":[68],"These":[69],"findings":[70],"should":[71],"be":[72],"important":[73],"for":[74],"control":[76,83],"purposes":[77],"manufacture":[80]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7598045","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
